What's New Is Old: "Cultural Lag" and Governance of Risk in the Life Sciences.

IF 4.9 2区 医学 Q1 MEDICINE, RESEARCH & EXPERIMENTAL
Jasmine C Arunachalam, David A Relman
{"title":"What's New Is Old: \"Cultural Lag\" and Governance of Risk in the Life Sciences.","authors":"Jasmine C Arunachalam, David A Relman","doi":"10.1101/cshperspect.a041953","DOIUrl":null,"url":null,"abstract":"<p><p>As advancement in the life sciences quickens, management of risks remains reactive, creating problematic delays in risk mitigation and difficulties for development of a holistic risk governance strategy. A reactive posture for addressing risk undermines biosecurity and contributes to public distrust in science. This problem is not new. A temporal offset between scientific advancement and oversight of associated risks was described more than a century ago. In 1922, the American sociologist, William Ogburn, coined the term, \"cultural lag.\" Cultural lag was premised on the interconnectedness of technology and society and referred to a period of maladjustment between the introduction of a new technology and societal responses to mitigate its downsides. We examine the consequences of cultural lag for risk governance in the life sciences by looking at three recently introduced technologies, CRISPR-Cas9 gene editing, the proposed creation of mirror life, and microbiome engineering. Our observations lead to three recommendations for addressing cultural lag. The first recommendation is structural, namely, consolidation of governmental oversight on emerging technologies; the second is goal-oriented, that is, a call for a holistic form of horizon scanning; and the third concerns process and calls for implementation of deliberative democratic principles and practices. By pursuing an anticipatory governance regime, with policymaking closely aligned to and coordinated with technology breakthroughs, we enhance research safety and security while promoting innovation, and as a secondary benefit, help to restore public trust in science.</p>","PeriodicalId":10452,"journal":{"name":"Cold Spring Harbor perspectives in medicine","volume":" ","pages":""},"PeriodicalIF":4.9000,"publicationDate":"2026-10-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Cold Spring Harbor perspectives in medicine","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1101/cshperspect.a041953","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"MEDICINE, RESEARCH & EXPERIMENTAL","Score":null,"Total":0}
引用次数: 0

Abstract

As advancement in the life sciences quickens, management of risks remains reactive, creating problematic delays in risk mitigation and difficulties for development of a holistic risk governance strategy. A reactive posture for addressing risk undermines biosecurity and contributes to public distrust in science. This problem is not new. A temporal offset between scientific advancement and oversight of associated risks was described more than a century ago. In 1922, the American sociologist, William Ogburn, coined the term, "cultural lag." Cultural lag was premised on the interconnectedness of technology and society and referred to a period of maladjustment between the introduction of a new technology and societal responses to mitigate its downsides. We examine the consequences of cultural lag for risk governance in the life sciences by looking at three recently introduced technologies, CRISPR-Cas9 gene editing, the proposed creation of mirror life, and microbiome engineering. Our observations lead to three recommendations for addressing cultural lag. The first recommendation is structural, namely, consolidation of governmental oversight on emerging technologies; the second is goal-oriented, that is, a call for a holistic form of horizon scanning; and the third concerns process and calls for implementation of deliberative democratic principles and practices. By pursuing an anticipatory governance regime, with policymaking closely aligned to and coordinated with technology breakthroughs, we enhance research safety and security while promoting innovation, and as a secondary benefit, help to restore public trust in science.

新即旧:生命科学中的“文化滞后”与风险治理。
随着生命科学进步的加快,风险管理仍然是被动的,造成了风险缓解方面的问题延误,并给制定整体风险治理战略带来了困难。应对风险的被动姿态破坏了生物安全,助长了公众对科学的不信任。这个问题并不新鲜。早在一个多世纪以前,人们就描述了科学进步与相关风险监管之间的时间抵消。1922年,美国社会学家威廉·奥格本(William Ogburn)创造了“文化滞后”一词。文化滞后是以技术和社会的相互联系为前提的,指的是新技术的引入和社会对其负面影响的缓解之间的一段不适应时期。我们通过研究最近引入的三种技术,即CRISPR-Cas9基因编辑、镜像生命的提议创造和微生物组工程,来研究文化滞后对生命科学风险治理的影响。我们的观察为解决文化滞后提出了三条建议。第一项建议是结构性的,即加强政府对新兴技术的监督;第二种是目标导向的,即要求整体形式的水平扫描;第三点涉及进程,要求实施协商民主的原则和做法。通过追求一种预期的治理机制,使政策制定与技术突破紧密结合和协调,我们在促进创新的同时加强了研究安全和保障,并作为次要利益,有助于恢复公众对科学的信任。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Cold Spring Harbor perspectives in medicine
Cold Spring Harbor perspectives in medicine MEDICINE, RESEARCH & EXPERIMENTAL-
CiteScore
14.30
自引率
1.90%
发文量
44
审稿时长
4-8 weeks
期刊介绍: Cold Spring Harbor Perspectives in Medicine is a monthly online publication comprising reviews on different aspects of a variety of diseases, covering everything from the molecular and cellular bases of disease to translational medicine and new therapeutic strategies. Cold Spring Harbor Perspectives in Medicine is thus unmatched in its depth of coverage and represents an essential source where readers can find informed surveys and critical discussion of advances in molecular medicine.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信
小红书